PNC Financial Services Group: West Pharmaceutical WST Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 9.7 M | Venta |
26,150
-2,238
| -8% | -USD 790 k | 0.01% | 611 |
|
|
2026
Q2 | USD 10.2 M | Compra |
28,388
+980
| +4% | +USD 300 k | 0.01% | 575 |
|
|
2026
Q1 | USD 6.87 M | Compra |
27,408
+827
| +3% | +USD 206 k | ﹤0.01% | 641 |
|
|
2025
Q4 | USD 7.31 M | Venta |
26,581
-427
| -2% | -USD 117 k | ﹤0.01% | 615 |
|
|
2025
Q3 | USD 7.08 M | Compra |
27,008
+84
| +0.3% | +USD 20.4 k | ﹤0.01% | 617 |
|
|
2025
Q2 | USD 5.89 M | Compra |
26,924
+4,145
| +18% | +USD 886 k | ﹤0.01% | 649 |
|
|
2025
Q1 | USD 5.1 M | Compra |
22,779
+3,315
| +17% | +USD 914 k | ﹤0.01% | 654 |
|
|
2024
Q4 | USD 6.38 M | Compra |
19,464
+1,489
| +8% | +USD 469 k | ﹤0.01% | 606 |
|
|
2024
Q3 | USD 5.4 M | Compra |
17,975
+955
| +6% | +USD 292 k | ﹤0.01% | 640 |
|
|
2024
Q2 | USD 5.61 M | Compra |
17,020
+1,399
| +9% | +USD 494 k | ﹤0.01% | 613 |
|
|
2024
Q1 | USD 6.18 M | Compra |
15,621
+870
| +6% | +USD 322 k | ﹤0.01% | 610 |
|
|
2023
Q4 | USD 5.19 M | Venta |
14,751
-7
| -0% | -USD 2.48 k | ﹤0.01% | 634 |
|
|
2023
Q3 | USD 5.54 M | Venta |
14,758
-234
| -2% | -USD 90.5 k | ﹤0.01% | 599 |
|
|
2023
Q2 | USD 5.73 M | Compra |
14,992
+1,037
| +7% | +USD 370 k | ﹤0.01% | 605 |
|
|
2023
Q1 | USD 4.84 M | Compra |
13,955
+763
| +6% | +USD 223 k | ﹤0.01% | 644 |
|
|
2022
Q4 | USD 3.1 M | Compra |
13,192
+122
| +0.9% | +USD 28.9 k | ﹤0.01% | 751 |
|
|
2022
Q3 | USD 3.22 M | Compra |
13,070
+538
| +4% | +USD 164 k | ﹤0.01% | 722 |
|
|
2022
Q2 | USD 3.79 M | Venta |
12,532
-241
| -2% | -USD 78.4 k | ﹤0.01% | 707 |
|
|
2022
Q1 | USD 5.25 M | Compra |
12,773
+610
| +5% | +USD 239 k | ﹤0.01% | 668 |
|
|
2021
Q4 | USD 5.7 M | Compra |
12,163
+1,029
| +9% | +USD 443 k | ﹤0.01% | 660 |
|
|
2021
Q3 | USD 4.73 M | Compra |
11,134
+245
| +2% | +USD 103 k | ﹤0.01% | 663 |
|
|
2021
Q2 | USD 3.91 M | Compra |
10,889
+148
| +1% | +USD 48.9 k | ﹤0.01% | 720 |
|
|
2021
Q1 | USD 3.03 M | Compra |
10,741
+749
| +7% | +USD 214 k | ﹤0.01% | 749 |
|
|
2020
Q4 | USD 2.83 M | Compra |
9,992
+625
| +7% | +USD 175 k | ﹤0.01% | 746 |
|
|
2020
Q3 | USD 2.58 M | Compra |
9,367
+24
| +0.3% | +USD 6.35 k | ﹤0.01% | 732 |
|
|
2020
Q2 | USD 2.12 M | Venta |
9,343
-1,834
| -16% | -USD 360 k | ﹤0.01% | 768 |
|
|
2020
Q1 | USD 1.7 M | Compra |
11,177
+135
| +1% | +USD 20.8 k | ﹤0.01% | 775 |
|
|
2019
Q4 | USD 1.66 M | Venta |
11,042
-3,250
| -23% | -USD 473 k | ﹤0.01% | 871 |
|
|
2019
Q3 | USD 2.03 M | Venta |
14,292
-6,616
| -32% | -USD 911 k | ﹤0.01% | 967 |
|
|
2019
Q2 | USD 2.62 M | Compra |
20,908
+675
| +3% | +USD 79.7 k | ﹤0.01% | 917 |
|
|
2019
Q1 | USD 2.23 M | Venta |
20,233
-3,719
| -16% | -USD 387 k | ﹤0.01% | 1002 |
|
|
2018
Q4 | USD 2.35 M | Compra |
23,952
+173
| +0.7% | +USD 18.8 k | ﹤0.01% | 939 |
|
|
2018
Q3 | USD 2.94 M | Compra |
23,779
+1,465
| +7% | +USD 164 k | ﹤0.01% | 938 |
|
|
2018
Q2 | USD 2.22 M | Compra |
22,314
+422
| +2% | +USD 38.8 k | ﹤0.01% | 1008 |
|
|
2018
Q1 | USD 1.93 M | Compra |
21,892
+2,672
| +14% | +USD 250 k | ﹤0.01% | 1044 |
|
|
2017
Q4 | USD 1.9 M | Compra |
19,220
+9,238
| +93% | +USD 906 k | ﹤0.01% | 1058 |
|
|
2017
Q3 | USD 961 k | Compra |
9,982
+3,890
| +64% | +USD 352 k | ﹤0.01% | 1312 |
|
|
2017
Q2 | USD 577 k | Venta |
6,092
-714
| -10% | -USD 65.7 k | ﹤0.01% | 1538 |
|
|
2017
Q1 | USD 556 k | Compra |
6,806
+175
| +3% | +USD 14.6 k | ﹤0.01% | 1559 |
|
|
2016
Q4 | USD 562 k | Venta |
6,631
-672
| -9% | -USD 52.8 k | ﹤0.01% | 1522 |
|
|
2016
Q3 | USD 544 k | Venta |
7,303
-10,510
| -59% | -USD 834 k | ﹤0.01% | 1514 |
|
|
2016
Q2 | USD 1.35 M | Venta |
17,813
-4,783
| -21% | -USD 348 k | ﹤0.01% | 1127 |
|
|
2016
Q1 | USD 1.57 M | Compra |
22,596
+8,765
| +63% | +USD 527 k | ﹤0.01% | 1059 |
|
|
2015
Q4 | USD 834 k | Venta |
13,831
-4,510
| -25% | -USD 271 k | ﹤0.01% | 1286 |
|
|
2015
Q3 | USD 993 k | Compra |
18,341
+103
| +0.6% | +USD 6 k | ﹤0.01% | 1227 |
|
|
2015
Q2 | USD 1.06 M | Compra |
18,238
+5,822
| +47% | +USD 325 k | ﹤0.01% | 1251 |
|
|
2015
Q1 | USD 747 k | Compra |
12,416
+329
| +3% | +USD 17.5 k | ﹤0.01% | 1383 |
|
|
2014
Q4 | USD 642 k | Compra |
12,087
+930
| +8% | +USD 46.5 k | ﹤0.01% | 1412 |
|
|
2014
Q3 | USD 500 k | Compra |
11,157
+50
| +0.5% | +USD 2.12 k | ﹤0.01% | 1485 |
|
|
2014
Q2 | USD 469 k | Compra |
11,107
+1,655
| +18% | +USD 70.9 k | ﹤0.01% | 1475 |
|
|
2014
Q1 | USD 416 k | Venta |
9,452
-3,898
| -29% | -USD 183 k | ﹤0.01% | 1499 |
|
|
2013
Q4 | USD 655 k | Venta |
13,350
-3,934
| -23% | -USD 184 k | ﹤0.01% | 1222 |
|
|
2013
Q3 | USD 711 k | Compra |
17,284
+3,584
| +26% | +USD 137 k | ﹤0.01% | 1162 |
|
|
2013
Q2 | USD 481 k | Compra |
+13,700
| Nuevas | +USD 451 k | ﹤0.01% | 1307 |
|
Otros fondos que tienen WST en su portafolio
Posición de PNC Financial Services Group en WST: resumen de T3 2026
PNC Financial Services Group redujo su participación en West Pharmaceutical (WST) en 7.9% durante T3 2026, al vender acciones por un valor estimado de USD 790 k y quedarse con 26,150 acciones valuadas en USD 9.7 M. La posición representa 0.01% del portafolio y ocupa el puesto #611.
PNC Financial Services Group reportó por primera vez una posición en WST en T2 2013 y desde entonces la ha mantenido en 54 trimestres. La posición alcanzó su máximo de USD 10.2 M en T2 2026. Al cierre de T3 2026, 878 fondos que sigue Wall St. Rank mantienen una posición en WST.
- Al cierre de T3 2026, PNC Financial Services Group tenía 26,150 acciones de West Pharmaceutical con un valor de USD 9.7 M.
- PNC Financial Services Group vendió 2,238 acciones de West Pharmaceutical en T3 2026, por un valor estimado de USD 790 k.
- West Pharmaceutical representó el 0.01% del portafolio de PNC Financial Services Group en T3 2026 y fue su posición número 611.
- PNC Financial Services Group reportó por primera vez una posición en West Pharmaceutical en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- La posición de PNC Financial Services Group en West Pharmaceutical alcanzó su máximo de USD 10.2 M en T2 2026.
- Al cierre de T3 2026, 878 fondos que sigue Wall St. Rank tenían West Pharmaceutical en su portafolio.
Según el informe 13F de PNC Financial Services Group correspondiente a T3 2026, presentado el 6 nov 2026.